Skip to main content
SpringerLink
Log in

Pediatric HIV

Antiretroviral Therapy

  • Chapter
Human Retroviral Infections

Part of the book series: Infectious Agents and Pathogenesis ((IAPA))

  • 112 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Connor, E. M., Sperling, R. S., Gelber, R., et al., 1994, Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment, N. Engl. J. Med. 331:1173–1180.

    Article  PubMed  CAS  Google Scholar 

  2. Borkowsky, W., Krasinski, K., Cao, Y., et al., 1994, Correlation of perinatal transmission of human immunodeficiency virus type 1 with maternal viremia and lymphocyte phenotypes, J.Pediatr.125:345.

    PubMed  CAS  Google Scholar 

  3. Perelson, A. S., Neumann, A. U., Markowitz, M., et al., 1996, HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time, Science 271:1582–1586.

    PubMed  CAS  Google Scholar 

  4. Mellors, J. W., Kingsley, L. A., Rinaldo, C. R., et al., 1995, Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion, Ann. Intern. Med. 122:573–579.

    PubMed  CAS  Google Scholar 

  5. Mellors, J. W., Munoz, A., Giorgi, J. V., et al., 1997, Plasmaviral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection, Ann. Intern. Med. 126:946–954.

    PubMed  CAS  Google Scholar 

  6. Hellerstein, M., Hanley, M. B., Cesar, D., Siler, S., et al., 1999, Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans, Nature Med. 5:83–89.

    PubMed  CAS  Google Scholar 

  7. Shearer, W. T., Quinn, T. C., LaRussa, P., et al., 1997, Viral load and disease progression in infants infected with human immunodeficiency virus type 1, N. Engl. J. Med. 336:1337–1342.

    Article  PubMed  CAS  Google Scholar 

  8. Hammer, S. M., Squires, K E., Hughes, M. D., Grimes, J. M., et al., 1997, A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team, N. Engl. J. Med. 337:725–733.

    Article  PubMed  CAS  Google Scholar 

  9. The National Institutes of Health Panel to Define Principles of Therapy of HIV Infection, 1997, Report of the NIH Panel to Define Principles of Therapy of HIV Infection. US. Public Health Service, Washington, D.C.

    Google Scholar 

  10. Working Group on Antiretroviral Therapy: National Pediatric HIV Resource Center, 1993, Antiretroviral therapy and medical management of the human immunodeficiency virus-infected child, Pediatr. Infect. Dis. 12:513–522.

    Google Scholar 

  11. CDC, 1998, Guidelines for the use of antiretroviral agents in pediatric HIV infection, Morbid. Mortal. Weekly Rep. 47:RR-4.

    Google Scholar 

  12. Yarchoan, R., Mitsuya, H., Myers, C. E., and Broder, S., 1989, Clinical pharmacology of 3’-azido 2’,3’ dideoxythymiden (zidovudine and related dideoxynucleosides), N. Engl. J. Med. 321:726–738.

    PubMed  CAS  Google Scholar 

  13. Pizzo, P. A., Eddy, J., Falloon, J., et al., 1988, Effect of continuous intravenous infusion of zidovudine (AZT) in childrenwith symptomatic HIV infection, N. Engl. J. Med. 31:889–896.

    Google Scholar 

  14. Pizzo, P., 1989, Emerging concept in the treatment of HIV infection in children, JAMA 26:1989–1992.

    Google Scholar 

  15. Brouwers, P., Mocs, H., Loolfus, P., et al., 1990, Effect of continuous-infusion zidovudine therapy on neurophysiologic functioning in children with symptomatic human immune deficiency virus infection, J. Pediatr. 117:980–985.

    PubMed  CAS  Google Scholar 

  16. McKinney, R. E., Maha, M. A., Connor, E. M., et al., 1991, A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease, J. Engl. J. Med. 324:1018–1025.

    Google Scholar 

  17. Blanche, S., Duliege, A.-M., Navarette, M. S., et al., 1991, Lowdose zidovudine in children with an human immunodeficiency virus type I infection acquired in the perinatal period, Pediatrics 88:364–370.

    PubMed  CAS  Google Scholar 

  18. Day, R. E., Mahu, M. A., Connor, E. M., et al., 1991, A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease, N. Engl. J. Med. 324:1018–1025.

    Google Scholar 

  19. Larder, B., and Kemp, S. C., 1989, Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT), Science 246:1155–1158.

    PubMed  CAS  Google Scholar 

  20. Butler, K. M., Husson, R. N., Balis, F. M., et al., 1991, Dideoxyinosine in children with symptomatic human immunodeficiency virus infection, N. Engl. J. Med. 324137–144.

    Google Scholar 

  21. Clerici, M., Roilides, E., Butler, K. M., DePalma, L., Shearer, G. M., and Pizzo, P. A., 1992, Changes in T-helper cell function in human immunodeficiency virus-infected children during didanosine therapy as a measure of antiretroviral activity, Blood 80:2196–2202.

    PubMed  CAS  Google Scholar 

  22. Lewis, L. L., Venzon, D., Church, J., et al., 1995, Laniivudine in children with human immunodeficiency virus infection, Pediatrics 96:247–252.

    Google Scholar 

  23. Kline, M. W., Dunkle, L. M., Church, J. A., et al., 1995, A phase 1/11 evaluation of stavudine (d4T) in children with human immunodeficiency virus infection, Pediatrics 96:247–252.

    PubMed  CAS  Google Scholar 

  24. Kline, M. W., Van Dyke, R. B., Lindsey, J. C., Gwynne, M., et al., 1998, A randomized comparative trial of stavudine (d4T) versus zidovudine (ZDV, AZT) in children with human immunodeficiency virus infection. AIDS Clinical Trials Group 240 Team, Pediatrics 101:214–220.

    Article  PubMed  CAS  Google Scholar 

  25. Palumbo, P. E., Raskino, C., Fiscus, S., et al., 1997, Correlation of HIV plasma RNA levels with clinical outcome in a large pediatric trial (ACTH 152), in Proceedings of the 4th Conference on Retroviruses and Opportunistic Infections, Washington, D.C., p. 208 [Abstract #LB14].

    Google Scholar 

  26. McKinney, R. E., Jr., Johnson, G. M., Stanley, K, Yong, F. H., et al., 1998, A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection. Pediatric AIDS Clinical Trails Group 300 Team, J. Pediatr. 133:500–508.

    PubMed  Google Scholar 

  27. Luzuriaga, K, Bryson, Y., Krogstad, P., et al., 1997, Combination treatment with zidovudine, didanosine and nevirapine in infants with human immunodeficiency virus type 1 infection, N. Engl. J. Med. 336:1343–1349.

    Article  PubMed  CAS  Google Scholar 

  28. Starr, S. E., Fletcher, C., Spector, S. A., et al., 1998, Efavirenz in combination with nelfinavir and nucleoside reverse transcriptase inhibitors (NRTZs) is safe and virologically effective in HIV-infected children, presented at the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, California, September 24–27, 1998 [Late breaker abstract LB-61.

    Google Scholar 

  29. Hsia, K., Yong, F., Starr, S., etal., 1999, HIV-1 plasma RNA load in children declines slowly to undetectable levels during effective antiretroviral therapy: implications of the Roche standard (std) and Ultrasensitive (ultra) assays, in Proceedings of the 6th Conference on Retroviruses and Opportunistic Infections, Chicago, Illinois [Abstract 270].

    Google Scholar 

  30. Danner, S. A., Carr, A., Leonard, J. M., et al., 1995, A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease, N. Engl. J. Med. 333:1528–1533.

    Article  PubMed  CAS  Google Scholar 

  31. Collier, A. C., Coombs, R. W., Schoenfeld, D. A., et al., 1996, Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine, N. Engl. J. Med. 334:1011–1017.

    Article  PubMed  CAS  Google Scholar 

  32. Stein, D. S., Fish, D. G., Bilello, J. A., Preston, S. L., et al., 1996, A 24-week open-label phase 1/11 evaluation of the HIV protease inhibitor MK-639 (indinavir), AlDS 10:485–492.

    CAS  Google Scholar 

  33. Nelson, R. P., Jr., Sleasman, J., Cervia, J., Scott, G., et al., 1999, Indinavir (IDV) in combination with stavudine (d4T) and lamivudine (3TC) in HIV-infected children, in Proceedings of the 6th Conference on Retroviruses and Opportunistic Infections, Chicago, Illinois [Abstract #425].

    Google Scholar 

  34. Martel, L., Valentine, M., Ferguson, L., Muelenaer, P., Fisher, R., Katz, S. L., and McKinney, R. E., 1999, Virologic and CD4 response to treatment with nelfinavir in therapy experienced, protease inhibitor naive HIV-infected children: 48 week follow-up, in: Proceedings of the 6th Conference on Retroviruses and Opportunistic Infections. Chicago, Illinois, p. 148 [Ab stract 429].

    Google Scholar 

  35. Balzarini, J., Naesens, L., Slachmuylders, J., Niphuis, H., Rosenberg, I., et al., 1991, 9-(2-Phosphonylmethoxyethyl) adenine (PMEA) effectively inhibits retrovirus replication in vitro and simian immunodeficiency virus infection in rhesus monkeys, AIDS 5:21–28.

    Article  PubMed  CAS  Google Scholar 

  36. American Academy of Pediatrics Committee on Pediatric AIDS, 1997, Evaluation and medical treatment of the HIV-exposed infant, Pediatrics 99909–916.

    Google Scholar 

  37. Nelson, R. P., Jr., Price, L. J., Halsey, A. B., Graven, S. N., Resnick, L., Day, N. R, Lockey, R. F., and Good, R. A,, 1996, Diagnosis of pediatric human immunodeficiency virus infection utilizing a commercially-available polymerase chain reaction gene amplification, Arch. Pediatr. Adolesc. Med. 150:40–45.

    PubMed  Google Scholar 

  38. McIntosh, R, Pitt, J., Brambilla, D., et al., 1994, Blood culture in the first 6 months oflife for diagnosis of vertically transmitted human immunodeficiency virus infection, J. Infect. Dis. 170:996–1000.

    PubMed  CAS  Google Scholar 

  39. Nesheim, S., Lee, F., Kalish, M. L., et al., 1997, Diagnosis of perinatal human immunodeficiency virus infection by polymerase chain reaction and p24 antigen detection after immune complex dissociation in an urban community hospital, J. Infect. Dis. 175:1333–1336.

    Article  PubMed  CAS  Google Scholar 

  40. Katzenstein, T. L., Pedersen, C., Nielson, C., Lundgren, J. D., Jakobsen, P. H., and Gerstoft, J., 1996, Longitudinal serum HIV RNA quantification: Correlation to viral phenotype at seroconversion and clinical outcome, AIDS 10:167–173.

    Article  PubMed  CAS  Google Scholar 

  41. Henrard, D. R., Phillips, J. F., Muenz, L. R., et. al., 1995, Natural history of cell-free viremia, JAMA 274:554–558.

    Article  PubMed  CAS  Google Scholar 

  42. Mofenson, L. M., Korelitz, J., Meyer, W. A., et al., 1997, The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children, J. Infect. Dis. 175:1029–1038.

    PubMed  CAS  Google Scholar 

  43. McIntosh, R, Shevitz, A., Zaknun, D., et al., 1996, Age-and time-related changes in extracellular viral load in children vertically infected by human immunodeficiency virus, Pediatr. Infect. Dis. J. 15:1087–1091.

    PubMed  CAS  Google Scholar 

  44. Abrams, E. J., Weedon, J. C., Lambert, G., Steketee, R., and the NYC Perinatal HIV Transmission Collaborative Study, 1996, HIVviral load early in life as a predictor of disease progression in HIV-infected infants, in: Proceedings of the XI International Conference on AIDS, Vancouver, Canada, p. 25 [Abstract We.B.311].

    Google Scholar 

  45. El-Sadar, W., Oleske, J. M., Agins, B. D., et al., 1994, Evaluation and Management of Early HIV Infection, Clinical Practice Guideline No. 7, AHCPR Publication No. 94-0572, Agency for Health Care Policy and Research Public Health Service, U.S. Department of Health and Human Services, Rockville, Maryland.

    Google Scholar 

  46. Pialow, G., Raffi, F., Brun-Vezinet, F., Meiffredy, V., Flandre, P., et al., 1998, A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1 infected patients. Trilege (Agence Nationale de Recherches sur le SIDA 072) Study Team, N. Engl. J. Med. 3391269–1276.

    Google Scholar 

  47. Havlir, D. V., Marschner, I. C., Hirsch, M. S., Collier, A. C., Tebas, P., et al., 1998, Maintenance antiretroviral therapies in HIV infected patients with undetectable plasma HIV RNA after tripledrug therapy. AIDS Clinical Trials Group Study 343 Team, N. Engl. J. Med. 3391261-1268.

    Google Scholar 

  48. Centers for Disease Control and Prevention, 1994, Revised classification system for human immunodeficiency virus infection in children less than 13 years of age, Morbid. Mortal. Weekly Rep. 43(RR-12):1–10.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Indiana University School of Medicine, Indianapolis, Indiana, 46202

    Robert P. Nelson Jr.

  2. Department of Pediatrics, College of Medicine, University of South Florida, Tampa, Florida, 33612

    Patricia J. Emmanuel

  3. Washington University School of Medicine, St. Louis, Missouri, 63110

    Maite De La Morena

Authors
  1. Robert P. Nelson Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Patricia J. Emmanuel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maite De La Morena
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of South Florida College of Medicine, Tampa, Florida

    Kenneth E. Ugen  & Herman Friedman  & 

  2. University of Pisa, Pisa, Italy

    Mauro Bendinelli

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

Nelson, R.P., Emmanuel, P.J., De La Morena, M. (2002). Pediatric HIV. In: Ugen, K.E., Bendinelli, M., Friedman, H. (eds) Human Retroviral Infections. Infectious Agents and Pathogenesis. Springer, Boston, MA. https://doi.org/10.1007/0-306-46819-0_15

Download citation

  • DOI: https://doi.org/10.1007/0-306-46819-0_15

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-46222-1

  • Online ISBN: 978-0-306-46819-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation